000 01193 a2200337 4500
005 20250515220311.0
264 0 _c20100805
008 201008s 0 0 eng d
022 _a1873-5576
024 7 _a10.2174/156800910791208535
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aXiao, Xiangshu
245 0 0 _aTargeting CREB for cancer therapy: friend or foe.
_h[electronic resource]
260 _bCurrent cancer drug targets
_cJun 2010
300 _a384-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Line, Tumor
650 0 4 _aCyclic AMP Response Element-Binding Protein
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPhosphorylation
650 0 4 _aProto-Oncogene Mas
700 1 _aLi, Bingbing X
700 1 _aMitton, Bryan
700 1 _aIkeda, Alan
700 1 _aSakamoto, Kathleen M
773 0 _tCurrent cancer drug targets
_gvol. 10
_gno. 4
_gp. 384-91
856 4 0 _uhttps://doi.org/10.2174/156800910791208535
_zAvailable from publisher's website
999 _c19730472
_d19730472